redirects uses disambiguation

food drug administration




agency overview


formed
june 1906 years 190606301


preceding agencies



food drug insecticide administration july 1927 july 1930
bureau chemistry usda july 1901 july 1927
division chemistry usda established 1862





jurisdiction
federal government united states


headquarters
white campus
10903 hampshire avenue
silver spring maryland 20993
39°02′07″n 76°58′59″w﻿ ﻿3903528°n 7698306°w﻿ 3903528 7698306


employees
14824 20102


annual budget
billion 20123


agency executive



scott gottlieb commissioner food drugs





parent agency
department health human services


child agencies



center biologics evaluation research
center devices radiological health
center drug evaluation research
center food safety applied nutrition
center tobacco products
center veterinary medicine
national center toxicological research
office criminal investigations
office regulatory affairs





website
wwwfdagov


food drug administration usfda federal agency united states department health human services united states federal executive departments responsible protecting promoting public health control supervision food safety tobacco products dietary supplements prescription overthecounter pharmaceutical drugs medications vaccines biopharmaceuticals blood transfusions medical devices electromagnetic radiation emitting devices ered cosmetics animal foods feed4 veterinary products 2017 34th budget approximately million funded pharmaceutical companies prescription drug user act56
empowered united states congress enforce federal food drug cosmetic serves primary focus agency also enforces laws notably section public health service associated regulations many directly related food drugs include regulating lasers cellular phones condoms control disease products ranging certain household pets sperm donation assisted reproduction
commissioner food drugs appointed president advice consent senate commissioner reports secretary health human services scott gottlieb current commissioner took 20177
headquarters unincorporated white maryland8 agency also field offices laboratories located throughout states united states virgin islands puerto rico3 2008 began post employees foreign countries including china india costa rica chile belgium united kingdom9




building houses office commissioner office regulatory department health human services10 agency consists fourteen centers officesnote





contents


organizational chart
location
regional facilities
scope funding
regulatory programs

canadaunited states regulatory cooperation council
regulation food dietary supplements
medications

medications

5311 advertising promotion
5312 postmarket safety surveillance


generic drugs

5321 generic drug scandal


overthecounter drugs
ebola treatment


vaccines blood tissue products biotechnology
medical radiationemitting devices
fdacleared fdaapproved
fdaapproved fdaaccepted food processing
cosmetics
cosmetic products
veterinary products
tobacco products
regulation living organisms


science research programs
data management
history

historical first endo pharmaceuticals opana 2017


21st century reforms

critical path initiative
patients rights access unapproved drugs
postmarketing drug safety monitoring
pediatric drug testing
priority review voucher
rules generic biologics
mobile medical applications


criticisms
also
references
notes
reading
external links



organizational chartedit


department health human services

food drug administration

office commissioner
office operations11

office equal employment opportunity
office human resources
office finance budget acquisition
office information management technology

office informatics technology innovation

director taha kasshout also holds post chief health informatics officer fda1213


office information management


office security operations
office facilities engineering mission support services


office policy planning legislation analysis
office medical products tobacco
center biologics evaluation research cber
center devices radiological health cdrh
center drug evaluation research cder
center tobacco products
office foods veterinary medicine
center veterinary medicine
center food safety applied nutrition cfsan
office global regulatory operations policy
national center toxicological research nctr
office regulatory affairs






locationedit
recent years agency began undertaking largescale effort consolidate operations washington metropolitan area moving main headquarters rockville several fragmented office buildings former site naval ordnance laboratory white area silver spring maryland814 site renamed white naval surface warfare center federal research center white first building life sciences laboratory dedicated opened employees campus december 2003 original building naval facility kept buildings construction15 project slated completed 2017 assuming future congressional funding
regional facilitiesedit
centers located washington area part headquarters divisions offices office regulatory affairs office criminal investigations primarily field offices workforce spread across country
office regulatory affairs considered eyes ears agency conducting vast majority fdas work field consumer safety officers commonly called investigators individuals inspect production warehousing facilities investigate complaints illnesses outbreaks review documentation case medical devices drugs biological products items difficult conduct physical examination take physical sample product
office regulatory affairs divided five regions divided districts districts based roughly geographic divisions federal court system district comprises main district office number resident posts remote offices serve particular geographic area also includes agencys network regulatory laboratories analyze physical samples taken though samples usually foodrelated laboratories equipped analyze drugs cosmetics radiationemitting devices
office criminal investigations established 1991 investigate criminal cases unlike investigators special agents armed dont focus technical aspects regulated industries agents pursue develop cases individuals companies committed criminal actions fraudulent claims knowingly willfully shipping known adulterated goods interstate commerce many cases pursues cases involving title violations conspiracy false statements wire fraud mail fraud addition prohibited acts defined chapter special agents often come criminal investigations backgrounds work closely federal bureau investigation assistant attorney general even interpol receives cases variety sources—including local agencies fbi—and works investigators help develop technical sciencebased aspects case smaller branch comprising agents nationwide
frequently works federal agencies including department agriculture drug enforcement administration customs border protection consumer product safety commission often local state government agencies also work provide regulatory inspections enforcement action
scope fundingedit
regulates trillion worth consumer goods consumer expenditures united states includes billion food sales billion drugs billion cosmetics billion vitamin supplements much expenditures goods imported united states responsible monitoring imports17
fdas federal budget request fiscal year 2012 totaled billion3 proposed 2014 budget billion18 billion budget generated user fees pharmaceutical firms majority fees18 used expedite drug reviews19 fdas federal budget request fiscal year 2008 october 2007 september 2008 totaled billion 1058 million increase received fiscal year 200720
february 2008 announced bush administrations 2009 budget request agency billion billion budget authority federal funding million user fees requested budget authority increase million 2008 funding three percent increase june 2008 congress gave agency emergency appropriation million 2008 another million17
federal laws concerning part food drug cosmetic act21 first passed 1938 extensively amended since codified title chapter united states code significant laws enforced include public health service parts controlled substances federal antitampering well many others many cases responsibilities shared federal agencies
regulatory programsedit


regulation therapeutic goods united states





prescription drugs
overthecounter drugs





federal food drug cosmetic
comprehensive drug abuse prevention control 1970
controlled substances
prescription drug marketing
drug price competition patent term restoration
hatchwaxman exemption
marihuana






government agencies
department health human services
food drug administration
department justice
drug enforcement administration






process
drug discovery
drug design
drug development
drug application
investigational drug
clinical trial phase
randomized controlled trial
pharmacovigilance
abbreviated drug application
fast track approval
offlabel






international coordination
international conference harmonisation technical
requirements registration pharmaceuticals human
uppsala monitoring centre
world health organization
council international organizations medical sciences
single convention narcotic drugs






nongovernmental organizations
institute medicine
research adverse drug events reports
norml















2015 agency regulates trillion consumer products including

billion food
billion drugs
billion cosmetics
billion vitamin supplements22

programs safety regulation vary widely type product potential risks regulatory powers granted agency example regulates almost every facet prescription drugs including testing manufacturing labeling advertising marketing efficacy safety—yet regulation cosmetics focuses primarily labeling safety regulates products published standards enforced modest number facility inspections inspection observations documented form
canadaunited states regulatory cooperation counciledit
february 2011 canadian prime minister stephen harper united states president barack obama issued declaration shared vision perimeter security economic competitiveness2324 announced creation canadaunited states regulatory cooperation council increase regulatory transparency coordination countries25
health canada united states food drug administration mandate undertook first kind initiative selecting first area alignment common cold indications certain overthecounter antihistamine ingredients 2013011026
regulation food dietary supplementsedit
main article regulation food dietary supplements food drug administration
regulation food dietary supplements food drug administration governed various statutes enacted united states congress interpreted pursuant federal food drug cosmetic accompanying legislation authority oversee quality substances sold food united states monitor claims made labeling composition health benefits foods
subdivides substances regulates food various categories—including foods food additives added substances manmade substances intentionally introduced food nevertheless dietary supplements specific standards exercises differ category next furthermore legislation granted variety means address violations standards given substance category
medicationsedit




building houses center drug evaluation research


center drug evaluation research uses different requirements three main drug product types drugs generic drugs overthecounter drugs drug considered made different manufacturer uses different excipients inactive ingredients used different purpose undergoes substantial change rigorous requirements apply molecular entities drugs based existing medications
medicationsedit
drugs receive extensive scrutiny approval process called drug application nda27 critics however argue standards sufficiently rigorous allowing unsafe ineffective drugs approved28 drugs available prescription default change overthecounter status separate process drug must approved first drug approved said safe effective used directed
rare limited exceptions multistep process involving animal testing controlled clinical trials granted compassionate protocols case 2015 ebola epidemic prescription authorization zmapp experimental treatments drugs used treat debilitating andor rare conditions existing remedies drugs satisfactory advance long period time studies progressively longer gradually adding individuals progress stage stage normally period years normally involve drug companies government laboratories often medical schools hospitals clinics however exceptions aforementioned process subject strict review scrutiny conditions given substantial amount research least preliminary human testing shown believed somewhat safe possibly effective
advertising promotionedit
fdas office prescription drug promotion reviews regulates prescription drug advertising promotion surveillance activities issuance enforcement letters pharmaceutical manufacturers advertising promotion overthecounter drugs regulated federal trade commission
drug advertising regulation29 contains broad requirements company advertise promote drug specific indication medical approved also advertisement must contain fair balance benefits risks side effects drug
term offlabel refers drug usage indications approved
postmarket safety surveillanceedit
approval sponsor must review report every patient adverse drug experience learns must report unexpected serious fatal adverse drug events within days events quarterly basis30 also receives directly adverse drug event reports medwatch program31 reports called spontaneous reports reporting consumers health professionals voluntary
remains primary tool postmarket safety surveillance requirements postmarketing risk management increasing condition approval sponsor required conduct additional clinical trials called phase trials cases requires risk management plans risk evaluation mitigation strategy rems drugs require actions taken ensure drug used safely3233 example thalidomide cause birth defects uses outweigh risks women taking drugs conceive child rems program thalidomide mandates auditable process ensure people taking drug take action avoid pregnancy many opioid drugs rems programs avoid addiction diversion drugs32
generic drugsedit
generic drugs chemical equivalents namebrand drugs whose patents expired34 general less expensive name brand counterparts manufactured marketed companies 1990s accounted third prescriptions written united states34 approval generic drug food drug administration requires scientific evidence generic drug interchangeable therapeutically equivalent originally approved drug35 called anda abbreviated drug application 2012 approved drugs available generic form
generic drug scandaledit
1989 major scandal erupted involving procedures used approve generic drugs sale public34 charges corruption generic drug approval first emerged 1988 course extensive congressional investigation oversight subcommitee united states house energy commerce committee resulted complaint brought mylan laboratories pittsburgh application manufacture generics subjected repeated delays mylan convinced discriminated soon began private investigation agency 1987 mylan eventually filed suit former employees four drugmanufacturing companies charging corruption within federal agency resulted racketeering violations antitrust order generic drugs approved employees even drug manufacturers submitted applications according mylan illegal procedure followed give preferential treatment certain companies summer 1989 three officials charles chang david brancato walter kletch pleaded guilty criminal charges accepting bribes generic drugs makers companies pharmaceutical subsidiary quad pharmaceuticals36 pleaded guilty giving bribes
furthermore discovered several manufacturers falsified data submitted seeking authorization market certain generic drugs vitarine pharmaceuticals york sought approval generic version drug dyazide medication high blood pressure submitted dyazide rather generic version tests april 1989 investigated manufacturers irregularities later brought number dozens drugs eventually suspended recalled manufacturers early 1990s securities exchange commission filed securities fraud charges bolar pharmaceutical company major generic manufacturer based long island york34
overthecounter drugsedit
overthecounter drugs like aspirin drugs combinations require doctors prescription37 list approximately approved ingredients combined various ways create 100000 drug products many drug ingredients previously approved prescription drugs deemed safe enough without medical practitioners supervision like ibuprofen38
ebola treatmentedit
2014 added ebola treatment developed canadian pharmaceutical company tekmira fast track program halted phase trials july pending receipt information drug works seen increasingly important face major outbreak disease west africa began late march 2014 continued august 2014update39
vaccines blood tissue products biotechnologyedit
center biologics evaluation research branch responsible ensuring safety efficacy biological therapeutic agents40 include blood blood products vaccines allergenics cell tissuebased products gene therapy products biologics required premarket approval process called biologics license application similar drugs
original authority government regulation biological products established 1902 biologics control additional authority established 1944 public health service along acts federal food drug cosmetic applies biologic products well originally entity responsible regulation biological products resided national institutes health authority transferred 1972
medical radiationemitting devicesedit




center devices radiological health


center devices radiological health cdrh branch responsible premarket approval medical devices well overseeing manufacturing performance safety devices41 definition medical device given includes products simple toothbrush complex devices implantable neurostimulators cdrh also oversees safety performance nonmedical devices emit certain types electromagnetic radiation examples cdrhregulated devices include cellular phones airport baggage screening equipment television receivers microwave ovens tanning booths laser products
cdrh regulatory powers include authority require certain technical reports manufacturers importers regulated products require radiationemitting products meet mandatory safety performance standards declare regulated products defective order recall defective noncompliant products cdrh also conducts limited amounts direct product testing
fdacleared fdaapprovededit
clearance requests medical devices prove substantially equivalent predicate devices already market approved requests items substantially different need demonstrate safety efficacy example inspected safety case toxic hazards aspects need proved provided submitter ensure proper procedures followed42
fdaapproved fdaaccepted food processingedit
approve applied coatings used food processing industry43 review process approve composition nonstick coatings inspect test materials governing processes however regulations cover formulation manufacturing nonstick coatings hence materials like polytetrafluoroethylene teflon cannot considered approved rather compliant acceptable
cosmeticsedit
cosmetics regulated center food safety applied nutrition branch regulates food cosmetic products general subject premarket approval unless make structure function claims make drugs cosmeceutical however color additives must specifically approved manufacturers include cosmetic products sold regulates cosmetics labeling cosmetics safety tested must bear warning effect
cosmetic productsedit
though cosmetic industry predominantly responsible ensuring safety products also power intervene necessary protect public general require premarket approval testing companies required place warning note products tested experts cosmetic ingredient reviews also play role monitoring safety influence ingredients also lack legal authority overall organization reviewed 1200 ingredients suggested several hundred restricted standard systemic method reviewing chemicals safety clear definition meant safety chemicals tested basis44
veterinary productsedit
center veterinary medicine branch regulates food additives drugs given animals45 regulate vaccines animals handled united states department agriculturecitation needed
cvms primary focus medications used food animals ensuring affect human food supply fdas requirements prevent spread bovine spongiform encephalopathy also administered inspections feed manufacturerscitation needed
tobacco productsedit
since family smoking prevention tobacco control became 2009 also authority regulate tobacco products46
2009 congress passed requiring color warnings cigarette packages printed advertising addition text warnings surgeon general47
nine graphic warning labels announced june 2011 scheduled required appear packaging september 2012 implementation date uncertain ongoing proceedings case reynolds tobacco food drug administration48 reynolds lorillard commonwealth brands liggett group santa natural tobacco company filed suit washington federal court claiming graphic labels unconstitutional forcing tobacco companies engage antismoking advocacy governments behalf49
first amendment lawyer floyd abrams representing tobacco companies case contending requiring graphic warning labels lawful product cannot withstand constitutional scrutiny50 association national advertisers american advertising federation also filed brief suit arguing labels infringe commercial free speech could lead government intrusion left unchallenged51 november 2011 federal judge richard leon district court district columbia temporarily halted labels likely delaying requirement tobacco companies display labels supreme court ultimately could decide matter52
july 2017 announced plan would reduce current levels nicotine permitted tobacco cigarettes53
regulation living organismsedit
acceptance premarket notification 510k k033391 january 2004 granted ronald sherman permission produce market medical maggots humans animals prescription medical device medical maggots represent first living organism allowed food drug administration production marketing prescription medical device
june 2004 cleared hirudo medicinalis medicinal leeches second living organism used medical device
also requires milk pasteurized remove bacteria
science research programsedit
addition regulatory functions carries research development activities develop technology standards support regulatory role objective resolving scientific technical challenges become impediments fdas research efforts include areas biologics medical devices drugs womens health toxicology food safety applied nutrition veterinary medicine54
data managementedit
collected large amount data decades march 2013 openfda created enable easy access data public
historyedit
main article history food drug administration
20th century federal laws regulating contents sale domestically produced food pharmaceuticals exception shortlived vaccine 1813 history traced latter part 19th century department agricultures division chemistry later bureau chemistry harvey washington wiley appointed chief chemist 1883 division began conducting research adulteration misbranding food drugs american market wileys advocacy came time public become aroused hazards marketplace muckraking journalists like upton sinclair became part general trend increased federal regulations matters pertinent public safety progressive era55 1902 biologics control place diphtheria antitoxin—derived tetanuscontaminated serum—was used produce vaccine caused deaths thirteen children louis missouri serum originally collected horse named contracted tetanus




harvey wiley chief advocate food drug


june 1906 president theodore roosevelt signed pure food drug also known wiley chief advocate55 prohibited penalty seizure goods interstate transport food adulterated applied similar penalties interstate marketing adulterated drugs standard strength quality purity active ingredient either stated clearly label listed united states pharmacopoeia national formulary56
responsibility examining food drugs adulteration misbranding given wileys usda bureau chemistry55 wiley used regulatory powers pursue aggressive campaign manufacturers foods chemical additives chemistry bureaus authority soon checked judicial decisions narrowly defined bureaus powers high standards proof fraudulent intent55 1927 bureau chemistrys regulatory powers reorganized usda body food drug insecticide organization name shortened food drug administration three years later57
1930s muckraking journalists consumer protection organizations federal regulators began mounting campaign stronger regulatory authority publicizing list injurious products ruled permissible 1906 including radioactive beverages mascara lash lure caused blindness worthless cures diabetes tuberculosis resulting proposed unable congress united states five years rapidly enacted following public outcry 1937 elixir sulfanilamide tragedy people died using drug formulated toxic untested solvent58
president franklin delano roosevelt signed food drug cosmetic june 1938 significantly increased federal regulatory authority drugs mandating premarket review safety drugs well banning false therapeutic claims drug labeling without requiring prove fraudulent intent soon passage 1938 began designate certain drugs safe supervision medical professional category prescriptiononly drugs securely codified 1951 durhamhumphrey amendment developments confirmed extensive powers enforce postmarketing recalls ineffective drugs55




medical officer alexander fleming examines portion 240volume drug application around late 1980s applications grew considerably efficacy mandate 1962 drug amendments


1959 thalidomide tragedy thousands european babies born deformed mothers took drug marketed treatment nausea pregnancies59 considering largely spared tragedy frances oldham kelsey refused authorize medication market 1962 kefauverharris amendment passed represented revolution regulatory authority60 important change requirement drug applications demonstrate substantial evidence drugs efficacy marketed indication addition existing requirement premarketing demonstration safety marked start approval process modern form
reforms effect increasing time difficulty required bring drug market61 important statutes establishing modern american pharmaceutical market 1984 drug price competition patent term restoration commonly known hatchwaxman chief sponsors extended patent exclusivity terms drugs tied extensions part length approval process individual drug generic manufacturers created approval mechanism abbreviated drug application anda generic drug manufacturer need demonstrate generic formulation active ingredient route administration dosage form strength pharmacokinetic properties bioequivalence corresponding brandname drug credited essence creating modern generic drug industry62
concerns length drug approval process brought fore early aids epidemic late 1980s actup activist organizations accused unnecessarily delaying approval medications fight opportunistic infections63 partly response criticisms issued rules expedite approval drugs lifethreatening diseases expanded preapproval access drugs patients limited treatment options64 initial drugs approved treatment hivaids approved accelerated approval mechanisms65 frank young commissioner behind action plan phase established august 1987 quicker approval aids medication66
instances state governments sought legalize drugs approved theory federal passed pursuant constitutional authority overrules conflicting state laws federal authorities still claim authority seize arrest prosecute possession sales substancescitation needed even states legal state first wave legalization states laetrile late 1970s drug used treatment cancer scientific studies legislative trend found ineffective6768 second wave concerned medical marijuana 1990s 2000s though virginia passed limited effect 1979 widespread trend began california 1996
historical first endo pharmaceuticals opana 2017edit
requested endo pharmaceuticals june 2017 remove oxymorphone hydrochloride market first request history69
21st century reformsedit
critical path initiativeedit
critical path initiative70 fdas effort stimulate facilitate national effort modernize sciences fdaregulated products developed evaluated manufactured initiative launched march 2004 release report entitled innovationstagnation challenge opportunity critical path medical products71
patients rights access unapproved drugsedit
compassionate investigational drug program created randall ruled favor robert randall 1978 creating program medical marijuana72
2006 court case abigail alliance eschenbach would forced radical changes regulation unapproved drugs abigail alliance argued must license drugs terminally patients desperate diagnoses completed phase testing73 case initial appeal 2006 decision reversed march 2007 rehearing supreme court declined hear case final decision denied existence right unapproved medications
critics fdas regulatory power argue takes long approve drugs might ease pain human suffering faster brought market sooner aids crisis created political efforts streamline approval process however limited reforms targeted aids drugs broader market call robust enduring reforms would allow patients care doctors access drugs passed first round clinical trials7475
postmarketing drug safety monitoringedit
widely publicized recall vioxx nonsteroidal antiinflammatory drug estimated contributed fatal heart attacks thousands americans played strong role driving wave safety reforms rulemaking statutory levels vioxx approved 1999 initially hoped safer previous nsaids reduced risk intestinal tract bleeding however number postmarketing studies suggested vioxx might increase risk myocardial infarction conclusively demonstrated results approve trial 200476
faced numerous lawsuits manufacturer voluntarily withdrew market example vioxx prominent ongoing debate whether drugs evaluated basis absolute safety safety relative existing treatments given condition wake vioxx recall widespread calls major newspapers medical journals consumer advocacy organizations lawmakers officials77 reforms fdas procedures post market drug safety regulation
2006 congressionally requested committee appointed institute medicine review pharmaceutical safety regulation issue recommendations improvements committee composed experts including leaders clinical medicinemedical research economics biostatistics public policy public health allied health professions well current former executives pharmaceutical hospital health insurance industries authors found major deficiencies current system ensuring safety drugs american market overall authors called increase regulatory powers funding independence fda7879 committees recommendations incorporated drafts pdufa bill signed 200780
2011 risk minimization action plans riskmaps created ensure risks drug never outweigh benefits drug within postmarketing period program requires manufacturers design implement periodic assessments programs effectiveness risk minimization action plans place depending overall level risk prescription drug likely pose public81
pediatric drug testingedit
prior 1990s drugs prescribed children united states tested safety efficacy pediatric population became major concern pediatricians evidence accumulated physiological response children many drugs differed significantly drugs effects adults children react different drugs many reason including size weight several reasons many medical trials done children many drugs children represented small proportion potential market drug manufacturers testing costeffective82
also children thought ethically restricted ability give informed consent increased governmental institutional hurdles approval clinical trials well greater concerns legal liability thus decades medicines prescribed children done nonfdaapproved offlabel manner dosages extrapolated adult data body weight bodysurfacearea calculations82
initial attempt address issue 1994 final rule pediatric labeling extrapolation allowed manufacturers pediatric labeling information required drugs tested pediatric safety efficacy bear disclaimer effect however rule failed motivate many drug companies conduct additional pediatric drug trials 1997 proposed rule require pediatric drug trials sponsors drug applications however rule successfully preempted federal court exceeding fdas statutory authority82
debate unfolding congress used 1997 food drug administration modernization pass incentives gave pharmaceutical manufacturers sixmonth patent term extension drugs submitted pediatric trial data reauthorizing provisions 2002 best pharmaceuticals children allowed request nihsponsored testing pediatric drug testing although requests subject funding constraints pediatric research equity 2003 congress codified fdas authority mandate manufacturersponsored pediatric drug trials certain drugs last resort incentives publicly funded mechanisms proved inadequate82
priority review voucher prvedit
priority review voucher provision food drug administration amendments 3580 signed president george bush signed bill september 2007 awards transferable priority review voucher company obtains approval treatment neglected tropical diseases system first proposed duke university faculty david ridley henry grabowski jeffrey 2006 health affairs paper developing drugs developing countries83 2012 president obama signed safety innovation includes section rare pediatric disease priority review voucher incentive program84
rules generic biologicsedit
since 1990s many successful drugs treatment cancer autoimmune diseases conditions proteinbased biotechnology drugs regulated center biologics evaluation research many drugs extremely expensive example anticancer drug avastin costs 55000 year treatment enzyme replacement therapy drug cerezyme costs 200000 year must taken gauchers disease patients life85
biotechnology drugs simple readily verifiable chemical structures conventional drugs produced complex often proprietary techniques transgenic mammalian cell cultures complexities 1984 hatchwaxman include biologics abbreviated drug application anda process essence precluding possibility generic drug competition biotechnology drugs february 2007 identical bills introduced house create anda process approval generic biologics passed85
mobile medical applicationsedit
2013 guidance issued regulate mobile medical applications protect users unintended guidance distinguishes apps subjected regulation based marketing claims apps86 incorporation guidelines development phase proposed expedite market entry clearance87
criticismsedit
main article criticism food drug administration



wikinews related news obama calls food safety system hazard public health


regulatory oversight large array products affect health life american citizens55 result fdas powers decisions carefully monitored several governmental nongovernmental organizations million 2006 institute medicine report pharmaceutical regulation found major deficiencies current system ensuring safety drugs american market overall authors called increase regulatory powers funding independence fda8889
nine scientists appealed presidentelect barack obama pressures management experienced george bush presidency manipulate data including relation review process medical devices characterized corrupted distorted current managers thereby placing american people risk concerns also highlighted 2006 report88 agency well90
also criticized opposite viewpoint tough industry according analysis published website libertarian mercatus center well published statements economists medical practitioners concerned consumers many feel oversteps regulatory powers undermines small business small farms favor large corporations three restrictions analysis permitting drugs devices control manufacturer speech imposition prescription requirements authors argue increasingly complex diverse food marketplace equipped adequately regulate inspect food91verification needed addition excessive regulation blamed rising costs health care creation monopolies potential competitors unable approval enter market compete keep health care costs down92
however indicator approval process particular medical devices 2011 study diana zuckerman paul brown national research center women families steven nissen cleveland clinic published archives internal medicine showed medical devices recalled last five years serious health problems death previously approved using less stringent cheaper 510k process cases devices deemed lowrisk need regulation devices recalled cardiovascular health purposes93
alsoedit


ethics portal
food portal
government united states portal
health fitness portal
portal
medicine portal



drug efficacy study implementation
food drug administration modernization 1997
food safety modernization 2011
fast track development program drugs
food drug administration amendments 2007 drugs
food drug administration safety innovation 2012 gainqidp
inverse benefit
investigational device exemption clinical trials
kefauver harris amendment 1962 required proofofefficacy drugs

general

adverse reaction
adverse event
adverse drug reaction

international

food administration
international conference harmonisation technical requirements registration pharmaceuticals human
brazil national health surveillance agency
canada marketed health products directorate
canada health canada
denmark danish medicines agency
european union european medicines agency
germany federal institute drugs medical devices
india food safety standards authority india
india central drugs standard control organization
japan ministry health labour welfare mhlw
japan pharmaceuticals medical devices agency
mexico federal commission protection sanitary risk
united kingdom medicines healthcare products regulatory agency
united states food drug administration

referencesedit


centennial 1906–2006 retrieved september 2008
partnership public service november 2012 state workforce washington author retrieved 2017
overview food drug administration retrieved august 2012
animal food feeds food drug administration retrieved march 2015
knezev sasha 2016 interview sidney wolfe american addict accessdate requires help
prescription drug user wwwfdagov food drug administration retrieved february 2017
mcginley laurie 2017 scott gottlieb confirmed lead food drug administration retrieved 2017
white campus information food drug administration february 2011 retrieved 2017
fdas international posts improving safety imported food medical products food drug administration retrieved april 2010
organization charts food drug administration august 2014 retrieved july 2015 agency within department health human services consists nine centers offices listed menu left
office operations organization organization charts food drug administration april 2015 retrieved july 2015
providing easy public access prescription drug overthecounter drug biological product labeling voice blog august 2014 footer retrieved july 2015
taylor nick paul march 2014 informatics chief immediate priority agency regulatory fiercebiotechit retrieved july 2015
coordinates headquarters white maryland 39°02′07″n 76°58′59″w﻿ ﻿390353363°n 769830894°w﻿ 390353363 769830894﻿ headquarters white maryland
meyer eugene february 2009 consolidates former navy site nytimescom retrieved 2014
white campus project schedule october 2015
gardiner harris november 2008 safety york times magazine
wright october 2013 drug takeback programs coming municipality near editors note life science leader pennsylvania vertmarkets knowledge park
elboghdady dina february 2012 budget stays billion washington post retrieved august 2012
2008 budget summary food drug administration retrieved march 2015
federal food drug cosmetic food drug administration retrieved march 2015
united states food drug administration httpwwwfdagov accessed october 2016
joint statement president obama prime minister harper canada regulatory cooperation white house whitehousegov february 2011 retrieved february 2011
president obama announce shared vision perimeter security economic competitiveness canada united states prime minister canada february 2011 retrieved february 2011
united statescanada regulatory cooperation council joint action plan developing implementing joint action plan washington office prime minister canada december 2011 archived original july 2013
notice regulatory cooperation council overthecounter products common monograph working group selection monograph alignment canadas action plan government canada january 2013 retrieved february 2013
drug application food drug administration retrieved november 2012
stegenga jacob drug regulation inductive risk calculus exploring inductive risk oxford university press
prescription drug advertising
31480 postmarketing reporting adverse drug experiences
medwatch safety information adverse event reporting program accessed october 2007
nelson perrone june 2014 assuring safety inherently unsafe medications risk evaluation mitigation strategies journal medical toxicology official journal american college medical toxicology 165–72 doi101007s131810130374z 4057549 pmid 24414251
brown bramlet ross underberg october 2016 roundtable risk evaluation mitigation strategy journal clinical lipidology 1288–1296 doi101016jjacl201610007 pmid 27919344
cohen lynne 1990 government policies programs united states generic drug scandal book knowledge medicine health 276–281 isbn 0717282449
therapeutic equivalence generic drugs food drug administration 1998 retrieved august 2012
details problems drug makers york times september 1989
regulation nonprescription drug products retrieved august 2012
cder handbook overthecounter drug products archived original 2009 retrieved october 2007
kliff sarah recently halted trials potential ebola treatment wwwvoxcom media retrieved august 2014
center biologics evaluation research cber march 2017 retrieved 2017
cdrh mission vision shared values retrieved august 2012
mean clears approves medical device food drug administration retrieved march 2015
approved coatings acceptable coatings decc company decc company decccom retrieved october 2013
ross 2006 perspective safety cosmetic products position paper american council science health toxicol 269–77 doi10108010915810600746049 pmid 16815815
modric september 2013 regulatory framework availability animal drugs united states veterinary clinics north america small animal practice 1005–12 doi101016jcvsm201304001 pmid 23890234
authority regulate tobacco products food drug administration
cigarette makers clash graphic news september 2011
overview cigarette health warnings food drug administration retrieved august 2012
koppel nathan september 2011 defends graphic cigarette labels wall street journal
tobacco gets first amendment lawyer suit adweek retrieved march 2015
tobacco allies warning label fight convenience store news retrieved march 2015
esterl mike november 2011 judge temporarily blocks graphic cigarette labels wall street journal
httpwwwnprorg20170728540088353fdaannouncesplantocutlevelofnicotineallowedincigarettes
science research food drug administration june 2009 retrieved november 2011
history part food drug administration retrieved march 2015
original text 1906 food drugs amendments
milestones food drug history
hamowy ronald february 2010 medical disasters growth retrieved september 2011
report congressman morris udall thalidomide kefauver hearings
temple 2002 policy developments regulatory approval statistics medicine 2939–2948 doi101002sim1298 pmid 12325110
frum david 2000 york york basic books isbn 0465041957
karki 2005 review related pharmaceuticals hatchwaxman regulatory amendments implications drug patent enforcement journal patent trademark office society 602–620
upny chronology 1988 retrieved march 2015
website expanded access expedited approval therapies related hivaids archived original november 2013
report accelerated approval process archived original 2009
richert lucas 2009 reagan regulation food drug administrations response hivaids 1980–90 canadian journal history
medicinal marijuana patientdriven phenomenon nprorg june 2010 retrieved march 2015
rise fall laetrile retrieved march 2015
requests removal opana risks related abuse press release silver spring maryland food drug administration june 2017 retrieved october 2017 today food drug administration requested endo pharmaceuticals remove opioid pain medication reformulated opana oxymorphone hydrochloride market first time agency taken steps remove currently marketed opioid pain medication sale public health consequences abusefda commissioner scott gottlieb facing opioid epidemic public health crisis must take necessary steps reduce scope opioid misuse abuse
fdagov
innovation stagnation challenge opportunity critical path medical products retrieved august 2012
httpswwwvicecomenusarticledp3e4ytheusgovernmenthassentthisguy300jointseachmonthfor34years
abigail alliance citizen petition
free choose medicine faster access drugs would save countless lives needless suffering bartley madden 9781934791325 amazoncom books retrieved march 2015
boldrin michele swamidass joshua july 2011 bargain drug approvals wall street journal
bresalier march 2005 cardiovascular events associated rofecoxib colorectal adenoma chemoprevention trial engl 1092–102 doi101056nejmoa050493 pmid 15713943
david grahams 2004 testimony congress retrieved august 2012
henderson diedtra september 2006 panel needs power funds boston globe webcitationorg
booksnapedu executive summary 2006 report future drug safety promoting protecting health public
food drug administration amendments fdaaa 2007 food drug administration retrieved march 2015
qato alexander 2011 postmarketing drug safety food drug administrations risk evaluation mitigation strategies jama 1595–1596 doi101001jama20111457 pmid 21990303
politis 2005 transition carrot stick evolution pharmaceutical regulations concerning pediatric drug testing widener review
ridley grabowski 2006 developing drugs developing countries health millwood 313–24 doi101377hlthaff252313 pmid 16522573
section rare pediatric disease priority review voucher incentive program public 112144 public july 2012 retrieved november 2015
amend public health service provide licensing comparable interchangeable biological products purposes 2007 110th congress 1038 govtrackus govtrackus retrieved march 2015
mobile medical applications food drug administration retrieved march 2015
yetisen martinezhurtado 2014 regulation mobile medical applications chip 833–840 doi101039c3lc51235e
henderson diedtra september 2006 panel needs power funds boston globe webcitationorg
committee assessment drug safety system 2006 future drug safety promoting protecting health public institute medicine free fulltext
mundy favole january 2009 scientists obama restructure drug agency wall street journal
williams richard robert scharff david bieler february 2010 food safety 21st century mercatus policy
httpsmisesorgbloglackepipencompetitorsfdasfault
medical device recalls approval process jama network retrieved march 2015


notesedit



quoted text source indicates actual count website indicates



readingedit

givel michael december 2005 philip morris gambit good public health journal public health policy 450–468
henninger daniel 2002 drug david henderson concise encyclopedia economics library economics liberty maint extra text editors list link oclc 317650570 50016270 163149563
hilts philip 2003 protecting americas health business hundred years regulation york alfred knopf isbn 037540466x
kevin fain matthew daubresse caleb alexander 2013 food drug administration amendments postmarketing commitments jama 3102 202–204 doi101001jama20137900
madden bartley 2010 free choose medicine faster access drugs would save countless lives needless suffering chicago heartland institute isbn 9781934791325
moore thomas 1998 prescription disaster hidden dangers medicine cabinet york simon schuster isbn 0684829983
obenchain janel arlene spark food policy looking forward past press 2015

external linksedit



wikimedia commons media related food drug administration united states





wikinews news related
food drug administration




official website
food drug administration federal register
organizational hierarchy chart format
strategic plan












food drug administration united states



divisions



center biologics evaluation research
center devices radiological health
center drug evaluation research
center food safety applied nutrition
center tobacco products
center veterinary medicine
national center toxicological research
office criminal investigations
office regulatory affairs








major acts



family smoking prevention tobacco control
modernization 1997
federal food drug cosmetic
food safety modernization
pdufa 1992
pure food drug





title regulations rules




administrative

title code federal regulations



federal journal

federal register



federal

title united states code






commissioners



harvey wiley
carl alsberg
charles browne
walter campbell
paul dunbar
charles crawford
george larrick
james goddard
herbert
charles edwards
alexander schmidt
donald kennedy
jere goyan
arthur hayes
frank edward young
david aaron kessler
jane henney
mark mcclellan
lester crawford
andrew eschenbach
margaret hamburg
robert califf
scott gottlieb





society culture



history food drug administration
criticism food drug administration
regulation food dietary supplements food drug administration

















agencies united states department health human services






headquarters hubert humphrey building


eric hargan acting secretary health human services deputy secretary health human services





secretariate staff offices



office secretary health human services
office deputy secretary health human services
office inspector general
office national coordinator health information technology








organizations directly
secretary health human services



administration community living





organizations
assistant secretary health



office assistant secretary health
public health service
public health service commissioned corps

surgeon general


office public health science
administration children families
administration aging
agency healthcare research quality
agency toxic substances disease registry
centers disease control prevention
centers medicare medicaid services
food drug administration
health resources services administration
indian health service
national institutes health
substance abuse mental health services administration

center behavioral health statistics quality







programs



child welfare information gateway
national toxicology program

















pharmaceutical industry united states



companies



abbott laboratories
acorda therapeutics
aderis pharmaceuticals
adolor corporation
alcon
alexion pharmaceuticals
alkermes
allergan
alza
amgen
amylin pharmaceuticals
ariad pharmaceuticals
avax technologies






regulatory bodies



food drug administration





professional bodies



american pharmacists association





miscellaneous



contract research organization
clinical research associate
drug
pharmaceutical industry
bangladesh
india
china
pakistan






books



billiondollar molecule 1994
america 2002
pharma 2006
side effects 2008
anatomy epidemic 2010
pharma 2012





lists



list drugs
list largest pharmaceutical settlements
list offlabel promotion pharmaceutical settlements
list pharmaceutical companies
list pharmaceutical manufacturers





related templates



pharmaceutical industry country


medicine
public health





related categories



pharmaceutical companies united states
australia
canada
finland
india
japan
switzerland







category















food safety



adulterants food contaminants



3mcpd
aldicarb
cyanide
formaldehyde
lead poisoning
melamine
mercury fish
sudan





flavorings



monosodium glutamate
salt
sugar

highfructose corn syrup







microorganisms



botulism
campylobacter jejuni
clostridium perfringens
escherichia coli o104h4
escherichia coli o157h7
hepatitis
hepatitis
listeria
norovirus
rotavirus
salmonella





parasitic infections food



amoebiasis
anisakiasis
cryptosporidiosis
cyclosporiasis
diphyllobothriasis
enterobiasis
fasciolopsiasis
fasciolosis
giardiasis
gnathostomiasis
paragonimiasis
toxoplasmosis
trichinosis
trichuriasis





pesticides



chlorpyrifos

lindane
malathion
methamidophos





preservatives



benzoic acid
ethylenediaminetetraacetic acid edta
sodium benzoate





sugar substitutes



acesulfame potassium
aspartame
saccharin
sodium cyclamate
sorbitol
sucralose





toxins poisons environment pollution



aflatoxin
arsenic contamination groundwater
benzene soft drinks
bisphenol
dieldrin
diethylstilbestrol
dioxin
mycotoxins
nonylphenol
shellfish poisoning





food contamination incidents



devon colic
1858 bradford sweets poisoning
1989 chilean grape scare
1993 jack coli outbreak
1996 odwalla coli outbreak
1999 orchard salmonellosis outbreak
2005 indonesia food scare
2006 north american coli o157h7 outbreaks
2007 vietnam food scare
2008 canada listeriosis outbreak
2008 chinese milk scandal
2008 irish pork crisis
2008 united states salmonellosis outbreak
2011 germany coli o104h4 outbreak
2011 taiwan food scandal
2011 united states listeriosis outbreak
2013 european aflatoxin contamination
2013 horse meat scandal
2013 taiwan food scandal
2014 taiwan food scandal
2015 united states coli outbreak
2017 brazil weak meat scandal
food safety incidents china
foodborne illness

outbreaks
death toll
united states


meat repackaging controversy
minamata disease
starlink corn recall
toxic syndrome





regulation standards watchdogs



acceptable daily intake
number
food labeling regulations
food libel laws
international food safety network
22000
quality assurance international





institutions



centre food safety
european food safety authority
institute food safety health
international food safety network
ministry food drug safety






coordinates 39°02′07″n 76°58′59″w﻿ ﻿3903528°n 7698306°w﻿ 3903528 7698306





retrieved httpsenwikipediaorgwindexphptitlefoodanddrugadministrationoldid818438754 categories food drug administration1906 establishments united statesamerican medical researchfood safety organizationsgovernment agencies established 1906regulators biotechnology productsunited states department health human services agenciesunited states public health servicehidden categories pages using citations accessdate urluse dates october 2017articles containing potentially dated statements august 2014all articles containing potentially dated statementsall articles unsourced statementsarticles unsourced statements april 2013articles unsourced statements june 2014all pages needing factual verificationwikipedia articles needing factual verification 2013cs1 maint extra text editors listcoordinates wikidata
